Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea
· Delayed Price · Currency is KRW 9,130.00
-70.00 (-0.76%)
At close: Dec 5, 2025
Ahn-Gook Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 43,372 | 15,844 | 28,991 | 18,219 | 13,650 | 12,768 | Upgrade
|
| Short-Term Investments | 2,300 | 2,300 | 5,050 | 11,050 | 7,496 | 6,877 | Upgrade
|
| Trading Asset Securities | 7,504 | 11,594 | 1,405 | 9,173 | 26,314 | 30,624 | Upgrade
|
| Cash & Short-Term Investments | 53,176 | 29,738 | 35,446 | 38,442 | 47,460 | 50,269 | Upgrade
|
| Cash Growth | 63.21% | -16.10% | -7.79% | -19.00% | -5.59% | -36.65% | Upgrade
|
| Accounts Receivable | 33,586 | 58,722 | 62,132 | 54,917 | 43,059 | 33,060 | Upgrade
|
| Other Receivables | 89.83 | 133.27 | 461.03 | 519.21 | 817.96 | 1,250 | Upgrade
|
| Receivables | 33,836 | 59,015 | 62,753 | 55,597 | 44,159 | 37,737 | Upgrade
|
| Inventory | 45,652 | 44,672 | 35,718 | 26,594 | 23,891 | 22,669 | Upgrade
|
| Prepaid Expenses | 322.47 | 223.64 | 130.74 | 75.04 | 90.25 | 211.36 | Upgrade
|
| Other Current Assets | 1,349 | 1,123 | 1,368 | 1,302 | 683.49 | 545.92 | Upgrade
|
| Total Current Assets | 134,335 | 134,772 | 135,416 | 122,010 | 116,285 | 111,432 | Upgrade
|
| Property, Plant & Equipment | 119,598 | 120,069 | 73,036 | 70,771 | 70,911 | 70,554 | Upgrade
|
| Long-Term Investments | 29,165 | 28,043 | 22,927 | 23,037 | 26,872 | 18,977 | Upgrade
|
| Other Intangible Assets | 3,702 | 3,901 | 4,287 | 4,087 | 3,874 | 3,378 | Upgrade
|
| Long-Term Deferred Tax Assets | 2,732 | 2,086 | 1,722 | 2,816 | 843.94 | 1,113 | Upgrade
|
| Other Long-Term Assets | 13,891 | 13,664 | 1,208 | 1,193 | 1,171 | 1,529 | Upgrade
|
| Total Assets | 303,423 | 302,535 | 238,598 | 223,912 | 219,956 | 206,984 | Upgrade
|
| Accounts Payable | 13,100 | 10,265 | 15,208 | 12,643 | 10,141 | 9,048 | Upgrade
|
| Accrued Expenses | 13,906 | 12,060 | 10,619 | 8,974 | 6,141 | 1,257 | Upgrade
|
| Short-Term Debt | 22,300 | 27,300 | 17,300 | 19,450 | 19,600 | 19,900 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 8.25 | 60.93 | 144.72 | Upgrade
|
| Current Portion of Leases | 198.79 | 197.36 | 259.14 | 336.51 | 296.49 | 357.66 | Upgrade
|
| Current Income Taxes Payable | 1,551 | 3,652 | 238.13 | 1,369 | 383.15 | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.78 | 18.55 | 3.23 | Upgrade
|
| Other Current Liabilities | 23,921 | 23,585 | 34,619 | 18,717 | 15,572 | 13,967 | Upgrade
|
| Total Current Liabilities | 74,976 | 77,059 | 78,242 | 61,498 | 52,212 | 44,678 | Upgrade
|
| Long-Term Debt | 50,000 | 50,000 | - | - | 8.25 | 69.18 | Upgrade
|
| Long-Term Leases | 308.43 | 226.52 | 120.27 | 210.13 | 225.69 | 332.83 | Upgrade
|
| Pension & Post-Retirement Benefits | 8,637 | 9,023 | 8,049 | 7,130 | 13,913 | 12,268 | Upgrade
|
| Other Long-Term Liabilities | 2,210 | 1,483 | 520.06 | 402.69 | 316.44 | 209.46 | Upgrade
|
| Total Liabilities | 136,131 | 137,792 | 86,932 | 69,241 | 66,675 | 57,558 | Upgrade
|
| Common Stock | 6,521 | 6,521 | 6,521 | 6,521 | 6,521 | 6,521 | Upgrade
|
| Additional Paid-In Capital | 15,531 | 15,531 | 15,531 | 15,531 | 15,531 | 15,547 | Upgrade
|
| Retained Earnings | 150,180 | 145,070 | 131,553 | 133,487 | 127,754 | 126,215 | Upgrade
|
| Treasury Stock | -4,941 | -4,941 | -4,941 | -4,941 | -4,387 | -3,967 | Upgrade
|
| Comprehensive Income & Other | 1,059 | 3,494 | 3,422 | 4,199 | 8,001 | 5,065 | Upgrade
|
| Total Common Equity | 168,351 | 165,676 | 152,086 | 154,798 | 153,421 | 149,380 | Upgrade
|
| Minority Interest | -1,059 | -932.34 | -420.65 | -126.44 | -140.14 | 45.11 | Upgrade
|
| Shareholders' Equity | 167,292 | 164,743 | 151,666 | 154,671 | 153,281 | 149,425 | Upgrade
|
| Total Liabilities & Equity | 303,423 | 302,535 | 238,598 | 223,912 | 219,956 | 206,984 | Upgrade
|
| Total Debt | 72,807 | 77,724 | 17,679 | 20,005 | 20,191 | 20,804 | Upgrade
|
| Net Cash (Debt) | -19,631 | -47,986 | 17,767 | 18,437 | 27,269 | 29,465 | Upgrade
|
| Net Cash Growth | - | - | -3.63% | -32.39% | -7.45% | -41.52% | Upgrade
|
| Net Cash Per Share | -1727.10 | -4222.08 | 1563.26 | 1620.25 | 2380.83 | 2329.62 | Upgrade
|
| Filing Date Shares Outstanding | 11.37 | 11.37 | 11.37 | 11.37 | 11.41 | 11.46 | Upgrade
|
| Total Common Shares Outstanding | 11.37 | 11.37 | 11.37 | 11.31 | 11.41 | 11.46 | Upgrade
|
| Working Capital | 59,359 | 57,713 | 57,174 | 60,511 | 64,072 | 66,754 | Upgrade
|
| Book Value Per Share | 14807.06 | 14577.25 | 13381.56 | 13683.36 | 13441.11 | 13035.90 | Upgrade
|
| Tangible Book Value | 164,649 | 161,774 | 147,799 | 150,711 | 149,547 | 146,002 | Upgrade
|
| Tangible Book Value Per Share | 14481.42 | 14233.98 | 13004.33 | 13322.13 | 13101.72 | 12741.09 | Upgrade
|
| Land | 36,756 | 36,756 | 19,501 | 19,501 | 19,501 | 19,501 | Upgrade
|
| Buildings | 77,522 | 77,096 | 34,393 | 19,510 | 34,222 | 33,855 | Upgrade
|
| Machinery | 45,460 | 42,522 | 34,066 | 29,974 | 33,184 | 31,149 | Upgrade
|
| Construction In Progress | 2,605 | 830.04 | 24,210 | 22,712 | 21,973 | 21,432 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.